PureHealth, a leading healthcare group in the Middle East, has confirmed its acquisition of a 60% stake in Hellenic Healthcare Group, a major private hospital operator in Greece and Cyprus. The deal, valued at $2.3 billion, marks PureHealth’s significant entry into the European healthcare market.

Hellenic Healthcare operates 10 hospitals and 16 diagnostic centers across Greece and Cyprus, with a combined capacity of 1,600 beds, serving approximately 1.4 million patients annually. The group employs over 6,700 healthcare professionals.

The transaction will leave CVC Capital Partners, the current majority stakeholder, with a 35% stake in Hellenic Healthcare, while the group’s founder retains 5%.

This acquisition aligns with PureHealth’s strategy to expand globally, with an ambitious goal of generating over 50% of its revenues from outside the GCC in the medium term. Hamad Al Hammadi, Chairman of PureHealth, told Gulf News, “The expansion into Europe strengthens our position as a global healthcare leader and our commitment to delivering transformative care and setting new standards of excellence globally.”

PureHealth has been actively pursuing international growth. It previously acquired the UK’s Circle Health Group for $1.2 billion and a 26.05% stake in Ardent Health Services in the US for $500 million in 2022.

Group CEO Shaista Asif emphasized that the Hellenic Healthcare acquisition would enhance revenue diversification, operational efficiency, and overall financial performance, further solidifying PureHealth’s vision of becoming a global healthcare leader.

PureHealth’s stock is currently trading at Dh3.59 on the Abu Dhabi Securities Exchange, with a 52-week high of Dh5.04. This latest move not only boosts its presence in Europe but also strengthens its global portfolio and market position.